biochemical profiling of lipids: applications to drug ... · biochemical profiling of lipids:...
TRANSCRIPT
![Page 1: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/1.jpg)
Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology
Steven M. Watkins, Ph.D. President/CSO
![Page 2: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/2.jpg)
Scientific Approach
• Building technology for understanding lipid metabolism in global and molecular detail. – Lipid metabolism in disease – Effects of foods and drugs on lipid metabolism – Lipids as central components of individual
health status
![Page 3: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/3.jpg)
Metabolomics Integrates
MetabolismDrugs
Nutrition Health
Exercise Disease
Environment
Genes
![Page 4: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/4.jpg)
Metabolic Assessment
• High-content analyses provide individual context
• Context allows interpretation
![Page 5: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/5.jpg)
Metabolomics provides both
Tools for Enabling Metabolic Assessment
• High-content, quantitative analysis of metabolites
• Analysis of flux through metabolic pathways
Metabolomics provides both
![Page 6: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/6.jpg)
Quantitative Analysis
PATIENT
Lipid Extract
SAMPLE
CLINICAL / HEALTH INFORMATION
Phosphatidylcholine
Phosphatidylserine
Phosphatidylethanolamine
Cardiolipin
Sphingomyelin
Phosphatidylinositol
Lyso-PLCholine
Triglycerides
Diacylglycerides
Monoacylglycerides
Free Fatty Acids
Cholesterol Esters
Sterols
DATABASE
![Page 7: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/7.jpg)
Surveyor® Data Visualization
![Page 8: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/8.jpg)
Steady-State Flux Analyses
ƒFlux
Experimental Quantitative Map Against Flux Models Analysis Pathway Signature
![Page 9: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/9.jpg)
Building Diagnostics for Metabolic Disease Therapy
Edward Leiter The Jackson Laboratory
![Page 10: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/10.jpg)
Profiling the Effects of Insulin-Sensitizing Drugs
• Investigated the effects of two diabetes drugs on lipid metabolism in a obese-diabetic model
• PPARγ agonist: Rosiglitazone • β-3 adrenergic agonist: CL316,243
![Page 11: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/11.jpg)
PPAR-γ β3-Adrenergic 450 350
400 300
350
250 300
L 250 L 200
r d r de 200 e p p 150 s s
mg 150
mg
100 100
50 50
0 0 Cholesterol Glucose Triglycerides Cholesterol Glucose Triglycerides
Control Treatment
Clinical Biomarkers
![Page 12: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/12.jpg)
PPAR-γ β3-Adrenergic 90 50
80 45
4070
3560
30
30 15
20 10
10 5
Gra
ms
0 0
Gra
ms 50
25 40
20
Body Weight post-treatment Body Weight post-treatment
Control Treatment
Body Weight Following Treatment
![Page 13: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/13.jpg)
PPAR-γ Treatment
![Page 14: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/14.jpg)
Hepatic Lipid Accumulation
![Page 15: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/15.jpg)
PPAR-γ Treatment
![Page 16: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/16.jpg)
β3-Adrenergic Agonist
![Page 17: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/17.jpg)
Hepatic Lipid Synthesis
PPAR-γ β-3 Agonist
![Page 18: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/18.jpg)
-100%
200%
-150% 150%
Hyp
o -lip
idem
icD
rug
A
-100%
200%
-150% 150%
Hyp
o -lip
idem
icD
rug
A
-100%
200%
-150% 150%
Hyp
o -lip
idem
icD
rug
AH
ypo -
lipid
emic
Dru
g A
De
De
De
Decccc
rrrreeeeaaaassss
eeeedddd w www
iiiitttthhhhIIIInnnn
crcrcrcreaeaeaea
sssseeeedddd
wwwwiiiitttthhhh
d dddrrrruuuu
gggg A AAA
drdrdrdrugugugug
A AAA
Plasma Metabolome Reveals Mechanism
Signature of lipogenesis
PPA
R-γ
Increased with drug BDecreased with drug B Increased with drug BDecreased with drug Increased with drug BDecreased with drug B
-100%
200%
-150% 150%
Increased with drug BDecreased with drug
All other metabolites
β3-Adrenergic 0
50
100
150
200
250
300
350
Cholesterol Glucose Triglycerides
mgs
per
dL
0
50
100
150
200
250
300
350
400
450
Cholesterol Glucose Triglycerides
mgs
per
dL
![Page 19: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/19.jpg)
Must know both the identity and quantity of each metabolite
Metabolic Assessment
• High-content assays are required to elucidate metabolic basis for phenotype
• Want data on both metabolite concentrations and metabolic flux
Must know both the identity and quantity of each metabolite
![Page 20: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/20.jpg)
Building Diagnostics
• Single chronic diseases have more than one metabolic (or environmental) cause
• Next generation diagnostics need to provide actionable information. – What dysregulation needs treatment?
• Metabolic assessment enables actionable, individual-specific diagnoses.
![Page 21: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/21.jpg)
Delivering Health to the Individual
Individual Dx Map to Pathway Action
![Page 22: Biochemical Profiling of Lipids: Applications to Drug ... · Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology . Steven M. Watkins, Ph.D. President/CSO](https://reader036.vdocuments.net/reader036/viewer/2022063000/5f0d7dcb7e708231d43a9f23/html5/thumbnails/22.jpg)
Biochemical Profiling of Lipids: Applications to Drug Development and Toxicology
Steven M. Watkins, Ph.D. President/CSO